Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROSPECTOR-2 Study: Prolonged versus Single Dose Penicillin Oral Challenge Testing
2025-520888-41-00Phase 4Authorised
- Sponsor
- Austin Health
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 4, randomised, double-blind trial of amoxicillin in penicillin allergy (2 arms), sponsored by Austin Health. Primary endpoint: Positive oral challenge up to day 7. Planned start Oct 2025; status: authorised.
02
Drugs
amoxicillin
03
Conditions
penicillin allergy
Beyond the preview
Go deeper on 2025-520888-41-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-520888-41-00.